StockData
biote Corp. logo

biote Corp. (BTMD) stock

BTMDNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/3065% below fair value
$0.89−0.10 (-10.51%)

Close on Nov 18, 2026Market cap $31.83MP/E 8.9Yield –

biote net income

Net income is the profit left for shareholders after every expense, interest and tax.

biote's net income for the twelve months ending Jun 30, 2026 was $5.86M, down 81.3% year over year. For fiscal 2025 it was $27.05M, up 756.7% from the year before. The highest annual figure on record is $27.05M in fiscal 2025.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$27.05M+756.7%
FY2024Dec 31, 2024$3.16M-4.8%
FY2023Dec 31, 2023$3.32M–
FY2022Dec 31, 2022-$969.00K-108.7%
FY2021Dec 31, 2021$11.11M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$6.56M-306.1%
Q1 FY2026Mar 31, 2026$2.28M-83.4%
Q4 FY2025Dec 31, 2025$1.95M-47.2%
Q3 FY2025Sep 30, 2025$8.19M-23.5%
Q2 FY2025Jun 30, 2025$3.19M–
Q1 FY2025Mar 31, 2025$13.72M–
Q4 FY2024Dec 31, 2024$3.70M-52.1%
Q3 FY2024Sep 30, 2024$10.70M+42.1%
Q2 FY2024Jun 30, 2024-$7.09M–
Q1 FY2024Mar 31, 2024-$4.16M–
Q4 FY2023Dec 31, 2023$7.73M+376.8%
Q3 FY2023Sep 30, 2023$7.53M+50100.0%
Q2 FY2023Jun 30, 2023-$5.14M–
Q1 FY2023Mar 31, 2023-$6.81M-679.4%
Q4 FY2022Dec 31, 2022$1.62M–
Q3 FY2022Sep 30, 2022$15.00K-99.5%
Q2 FY2022Jun 30, 2022-$2.61M-119.7%
Q1 FY2022Mar 31, 2022$1.17M–
Q4 FY2021Dec 31, 2021-$1.18M–
Q3 FY2021Sep 30, 2021$3.00M–
Q2 FY2021Jun 30, 2021$13.24M–
Q1 FY2021Mar 31, 2021-$3.94M–

More biote figures

See a number that looks wrong?